Because FFA2 is thought to stimulate the release GLP-1 from EECs, the absence of the receptor might lead to the opposite observation: an impaired GLP-1 response leading to hyperglycemia and diminished insulin release. The gene discussed is INS; the disease is Hyperglycemia.